Concepedia

Janie Parrino

JP

Statistics

Publications

24

Citations

2.2K

H-Index

22

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Regeneron (United States)

Sanofi (United States)

Dalhousie University

National Institute of Allergy and Infectious Diseases

Janie Parrino is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, veterinary medicine, and vaccinology.

Publications per year

2006–2022

24

Publications

24

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

Melissa Precopio, Michael R. Betts, Janie Parrino et al. · The Journal of Experimental Medicine · 2007 · 486 citations · Full text

, , +16

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

Ken Schmader, Myron J. Levin, J. W. Gnann et al. · Clinical Infectious Diseases · 2012 · 431 citations · Full text

, , +17

Subunit Recombinant Vaccine Protects against Monkeypox

Jean‐Michel Héraud, Yvette Edghill‐Smith, Victor I. Ayala et al. · The Journal of Immunology · 2006 · 183 citations · Full text

, , +17

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis

Paul Emery, Juan Rondon, Janie Parrino et al. · Lara D. Veeken · 2018 · 124 citations · Full text

, , +13

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

Peter B. Gilbert, Erin E. Gabriel, Xiaopeng Miao et al. · The Journal of Infectious Diseases · 2014 · 100 citations · Full text

, , +17

1–5 of 24